Show Summary Details
Page of

HIV: antiretroviral treatment and emergence of resistance 

HIV: antiretroviral treatment and emergence of resistance
HIV: antiretroviral treatment and emergence of resistance

Daniel Bradshaw

, and Amber Arnold

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 02 July 2022

HIV resistance continues to pose a problem in the choice for effective regimens despite the arrival of newer antiretroviral agents. The emergence of resistance is dependent on both physician factors (for example, interpreting resistance information appropriately and prescribing medications at the correct dose and in effective combinations) as well as patient-related factors relating to adherence. This chapter presents a case where both areas were not ideal. The role of genotypic assays is evaluated and the interpretation of resistance data and choices of antiretroviral agents discussed.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.